Merck (MRK) Non-Current Assets (2009 - 2026)

Merck (MRK) has 18 years of Non-Current Assets data on file, last reported at $125.0 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $125.0 million, down 99.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.0 million (down 99.96% YoY), and the FY2025 annual result was $125.0 million, changed N/A from the prior year.
• Non-Current Assets held at $125.0 million in Q1 2026 per MRK's latest filing, from $125.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $82.0 billion in Q3 2025 and troughed at $125.0 million in Q4 2025.
• A 5-year average of $66.5 billion and a median of $74.5 billion in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2026: Non-Current Assets climbed 20.89% in 2022, then tumbled 99.84% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $73.4 billion in 2022, then grew by 1.46% to $74.5 billion in 2023, then increased by 3.58% to $77.2 billion in 2024, then sank by 99.84% to $125.0 million in 2025, then changed by 0.0% to $125.0 million in 2026.
• Business Quant data shows MRK's Non-Current Assets at $125.0 million in Q1 2026, $125.0 million in Q4 2025, and $82.0 billion in Q3 2025.